Winbro Pharma Private Limited
About Winbro Pharma Private Limited
Data last updated:
Winbro Pharma Private Limited is a private limited company based in Chennai, Tamil Nadu, India, a subsidiary of Windia Chemicals Private Limited. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 05 December 2003 and has been in existence for over 23 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U24231TN2003PTC052087. Its GSTIN is 33AAACW5160G1ZK (Tamil Nadu).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹8 Lakh. It is led by directors Renganathan Pappu Reddiar and Malarselvi Renganathan.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 41 3rd Street V.G.P Layout Injambakkam, Chennai, Tamil Nadu, India – 600041.
As per the financials filed for FY 2025, the company reported a revenue of ₹18.64 Lakh, a decline of 50% compared to the previous year. For the same year it recorded a net loss of ₹23.79 Lakh (net margin -127.6%) and EBITDA of -₹12.78 Lakh (EBITDA margin -68.6%). Revenue has declined at a compounded annual rate (CAGR) of 2% over three years and 24% over five years.
As per MCA filings, the company has open charges of ₹5.55 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address41 3rd Street V.G.P Layout Injambakkam, Chennai, Tamil Nadu, India – 600041
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Winbro Pharma Private Limited
The main business activity of Winbro Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Winbro Pharma Private Limited FY 2025 filings available
Winbro Pharma Private Limited reported revenue of ₹18.64 Lakh (down 50% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Winbro Pharma Private Limited
Revenue has declined at a compounded annual rate (CAGR) of 24% over five years, including a 50% fall in the latest year. EBITDA fell 83% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Winbro Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | -₹12.78 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹23.79 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Winbro Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -68.6% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -127.6% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Winbro Pharma are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Winbro Pharma Private Limited
Winbro Pharma Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Revenue, net profit, margin and growth of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Stickler Technologies Private Limited | •••• | •••• | •••• | •••• | - | Gandhinagar, Gujarat, India |
| Amerise Biosciences Limited Listed | •••• | •••• | •••• | •••• | - | Ahmedabad, Gujarat, India |
| Eco Pharmacure Healthcare Private Limited | •••• | •••• | •••• | •••• | - | Ulwe, Maharashtra, India |
| Life Labs Private Limited | •••• | •••• | •••• | •••• | - | Kolkata, West Bengal, India |
| T A Majeed S Fair Pharma Private Limited | •••• | •••• | •••• | •••• | - | Coimbatore, Tamil Nadu, India |
| Winbro Pharma Private Limited this company | •••• | •••• | •••• | •••• | - | Chennai, Tamil Nadu, India |
| Creme-De-La-Creme Private Limited | •••• | •••• | •••• | •••• | - | Mumbai, Maharashtra, India |
| Medworld Pharmaceuticals Private Limited | •••• | •••• | •••• | •••• | - | Thane, Maharashtra, India |
| Natural Solutions and Neutraceuticals Private Limited | •••• | •••• | •••• | •••• | - | Mumbai, Maharashtra, India |
| Aartha Pharmaceuticals Private Limited | •••• | •••• | •••• | •••• | - | Tirumalagiri, Telangana, India |
| Kannikkatt Pharmaceuticals Private Limited | •••• | •••• | •••• | •••• | - | Kottayam, Kerala, India |
Peers are the five companies nearest above and the five nearest below Winbro Pharma by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Revenue, net profit, margin and growth of each peer are in the company report.
Auditor Details of Winbro Pharma Private Limited
Winbro Pharma Private Limited is audited by A.VENKATESAN & ASSOCIATES for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| A.VENKATESAN & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Winbro Pharma Private Limited
Winbro Pharma has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Renganathan Pappu Reddiar | Director | 05 Dec 2003 | 22 Years 10 Months | Current |
| Malarselvi Renganathan | Director | 02 Nov 2020 | 5 Years 11 Months | Current |
Ownership and Shareholding of Winbro Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Winbro Pharma Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 12 Apr 2022 | Hdfc Bank Limited | ₹5.55 Lakh | Open |
Total charge records: 1 View all charges
MSME Payment Delays by Winbro Pharma Private Limited
Winbro Pharma Private Limited has 2 MSME Form 1 returns on record for the period ending Mar 2019, listing 2 overdue payments to 1 micro and small supplier. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (1 of 1)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | •••• | •••• | •••• |
Full MSME payment history
Every supplier, amount and due date from all 2 MSME Form 1 returns is in the company report.
- Every reported supplier due
- Amounts and due dates
- Reasons given in each return
- Period-by-period history
Verified entity values are shown only after access is granted.
Individuals and sole proprietors among the suppliers are not named. Amounts, due dates and filing dates are in the company report.
Employees and EPFO Compliance at Winbro Pharma Private Limited
Employment history and EPFO contributions of people linked to Winbro Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Winbro Pharma Private Limited
Winbro Pharma Private Limited has 6 board changes on record since 2003: 2 appointments and 4 cessations. The latest: Thuvaarakkesh Ramanathan ceased to be Director on 05 May 2023.
Credit Ratings, Litigation & Regulatory Alerts for Winbro Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Winbro Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Winbro Pharma Private Limited
Winbro Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 33AAACW5160G1ZK | Tamil Nadu | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Winbro Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Winbro Pharma Private Limited
Winbro Pharma is an active private limited company based in Chennai, Tamil Nadu, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 05 December 2003 (23+ years old) and is registered under CIN U24231TN2003PTC052087.
Winbro Pharma reported revenue of ₹18.64 Lakh for FY 2025 (down 50% YoY).
Winbro Pharma has 2 current directors:
- Renganathan Pappu Reddiar - Director
- Malarselvi Renganathan - Director
Winbro Pharma reported a net loss of ₹23.79 Lakh (net margin -127.6%) and EBITDA of -₹12.78 Lakh (EBITDA margin -68.6%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Winbro Pharma is 2% over three years and -24% over five years. In the latest year (FY 2025) revenue fell 50%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Winbro Pharma is 33AAACW5160G1ZK, registered in Tamil Nadu.
The CIN (Corporate Identification Number) of Winbro Pharma is U24231TN2003PTC052087. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Winbro Pharma was incorporated on 05 December 2003, making it 23+ years old. It is registered with the Registrar of Companies, Chennai.
The peers of Winbro Pharma by revenue are Stickler Technologies Private Limited, Amerise Biosciences Limited, Eco Pharmacure Healthcare Private Limited, Life Labs Private Limited, T A Majeed S Fair Pharma Private Limited and 5 more, all in the Pharma industry (Formulations).
Thuvaarakkesh Ramanathan ceased to be Director on 05 May 2023. Malarselvi Renganathan was appointed as Director on 02 Nov 2020. Pandurangan Balakrishnan ceased to be Director on 30 Mar 2019. Winbro Pharma has 6 board changes on record in total.
Winbro Pharma has 2 MSME Form 1 returns on record for the period ending Mar 2019, listing 2 overdue payments to 1 micro and small supplier. The latest return was filed on 20 May 2019.
The registered office of Winbro Pharma is at 41 3rd Street V.G.P Layout Injambakkam, Chennai, Tamil Nadu, India – 600041.